This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dveksler, G. S.
Right arrow Articles by Holmes, K. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dveksler, G. S.
Right arrow Articles by Holmes, K. V.

 Previous Article  |  Next Article 

J. Virol., 01 1995, 543-546, Vol 69, No. 1
Copyright © 1995, American Society for Microbiology

Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain

GS Dveksler, AA Basile, CB Cardellichio and KV Holmes
Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.

Mouse hepatitis virus binds to the N-terminal domain of its receptor, MHVR, a murine biliary glycoprotein with four immunoglobulin-like domains (G.S. Dveksler, M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A.A. Basile, P.E. Elia, and K. V. Holmes, Proc. Natl. Acad. Sci. USA 90:1716-1720, 1993). A recombinant protein with only the anchored N-terminal domain was not a functional receptor, but a recombinant protein with the N-terminal domain of MHVR linked to the second and third immunoglobulin-like domains and anchor from the mouse poliovirus receptor homolog, mph, was a functional receptor for mouse hepatitis virus. The native four-domain MHVR has 16 potential N-linked glycosylation sites, including three on the N-terminal domain. Recombinant proteins lacking each one of these three sites or all three of them were functional receptors. Thus, glycosylation of the N- terminal domain is not required, but a glycoprotein longer than the N- terminal domain is required for virus receptor activity.


This article has been cited by other articles:

  • Wurdinger, T., Verheije, M. H., Broen, K., Bosch, B. J., Haijema, B. J., de Haan, C. A. M., van Beusechem, V. W., Gerritsen, W. R., Rottier, P. J. M. (2005). Soluble Receptor-Mediated Targeting of Mouse Hepatitis Coronavirus to the Human Epidermal Growth Factor Receptor. J. Virol. 79: 15314-15322 [Abstract] [Full Text]  
  • Comegys, M. M., Lin, S.-H., Rand, D., Britt, D., Flanagan, D., Callanan, H., Brilliant, K., Hixson, D. C. (2004). Two Variable Regions in Carcinoembryonic Antigen-related Cell Adhesion Molecule1 N-terminal Domains Located in or Next to Monoclonal Antibody and Adhesion Epitopes Show Evidence of Recombination in Rat but Not in Human. J. Biol. Chem. 279: 35063-35078 [Abstract] [Full Text]  
  • Miura, H. S., Nakagaki, K., Taguchi, F. (2004). N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein. J. Virol. 78: 216-223 [Abstract] [Full Text]  
  • Matsuyama, S., Taguchi, F. (2002). Receptor-Induced Conformational Changes of Murine Coronavirus Spike Protein. J. Virol. 76: 11819-11826 [Abstract] [Full Text]  
  • Taguchi, F., Matsuyama, S. (2002). Soluble Receptor Potentiates Receptor-Independent Infection by Murine Coronavirus. J. Virol. 76: 950-958 [Abstract] [Full Text]  
  • Klausegger, A., Strobl, B., Regl, G., Kaser, A., Luytjes, W., Vlasak, R. (1999). Identification of a Coronavirus Hemagglutinin-Esterase with a Substrate Specificity Different from Those of Influenza C Virus and Bovine Coronavirus. J. Virol. 73: 3737-3743 [Abstract] [Full Text]  
  • Zelus, B. D., Wessner, D. R., Williams, R. K., Pensiero, M. N., Phibbs, F. T., deSouza, M., Dveksler, G. S., Holmes, K. V. (1998). Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor, Bgp1b, and Bgp2 Murine Coronavirus Receptors Differ in Mouse Hepatitis Virus Binding and Neutralizing Activities. J. Virol. 72: 7237-7244 [Abstract] [Full Text]  
  • Rao, P. V., Gallagher, T. M. (1998). Intracellular Complexes of Viral Spike and Cellular Receptor Accumulate during Cytopathic Murine Coronavirus Infections. J. Virol. 72: 3278-3288 [Abstract] [Full Text]  
  • Wessner, D. R., Shick, P. C., Lu, J.-H., Cardellichio, C. B., Gagneten, S. E., Beauchemin, N., Holmes, K. V., Dveksler, G. S. (1998). Mutational Analysis of the Virus and Monoclonal Antibody Binding Sites in MHVR, the Cellular Receptor of the Murine Coronavirus Mouse Hepatitis Virus Strain A59. J. Virol. 72: 1941-1948 [Abstract] [Full Text]